FDA considers limiting authorization of certain monoclonal antibody treatments

Summary by Ground News
Federal regulators are considering limiting the authorization of certain monoclonal antibody treatments. The treatments have not proved effective against the Omicron variant of the coronavirus. The US Food and Drug Administration could decide in the coming days to take steps to curb the use of the treatments.
4 months ago·Washington, United States

News Articles

CNN

FDA considers limiting authorization of certain monoclonal antibody treatments

Federal regulators are considering limiting the authorization of certain monoclonal antibody treatments that have not proved effective against the Omicron variant of the coronavirus, a source familiar with the decision-making told CNN.

4 months ago·Atlanta, United States
Read Full Article
KVIA

FDA considers limiting authorization of certain monoclonal antibody treatments

By Steve Contorno, CNNFederal regulators are considering limiting the authorization of certain monoclonal antibody treatments that have not proved effective against the Omicron variant of the coronavirus, a source familiar with the decision-making told CNN.The US Food and Drug Administration could decide in the coming days to take steps to curb the use of antibody treatments produced by Eli Lilly and Regeneron, the source said, pointing to the g…

4 months ago
Read Full Article
KRDO

FDA considers limiting authorization of certain monoclonal antibody treatments

By Steve Contorno, CNNFederal regulators are considering limiting the authorization of certain monoclonal antibody treatments that have not proved effective against the Omicron variant of the coronavirus, a source familiar with the decision-making told CNN.The US Food and Drug Administration could decide in the coming days to take steps to curb the use of antibody treatments produced by Eli Lilly and Regeneron, the source said, pointing to the g…

4 months ago
Read Full Article
abc 7 NY

COVID Omicron News: FDA considers limiting authorization of certain monoclonal antibody treatments

The agency points to the growing body of evidence that shows some monoclonal therapies don't effectively neutralize the virus' omicron variant, according to a source.

4 months ago·New York, United States
Read Full Article
WISH-TV

FDA considers limiting authorization of certain monoclonal antibody treatments

(CNN) -- Federal regulators are considering limiting the authorization of certain monoclonal antibody treatments that have not proved effective against the omicron variant of the coronavirus, a source familiar with the decision-making told CNN. The U.S. Food and Drug Administration could decide in the coming

4 months ago
Read Full Article
The Daily Beast

FDA Push to Restrict Ron DeSantis’ Favorite Monoclonal Antibody COVID Treatment

The FDA wants to restrict monoclonal antibody treatment, citing dodgy science. Florida’s governor Ron DeSantis has pushed the treatment over vaccines.

4 months ago·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

75% of the sources lean Left
CNN
The Daily Beast
WISH-TV
abc 7 NY
L 75%
C 25%
Untracked bias
See less detail